health
Rare antibodies could point toward a future treatment for alpha-gal syndrome
NIH researchers identified rare antibodies that blocked human allergic antibodies from binding alpha-gal-containing red-meat allergens in laboratory tests, a finding that could inform future therapies but is not yet a treatment.